National Investigation in College and High School Among Adolescents on Health and Substances at the FSEF
NCT ID: NCT05225441
Last Updated: 2022-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
598 participants
OBSERVATIONAL
2022-03-01
2022-06-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Describe the young people hospitalised in residential care at the FSEF, in particular through vulnerability factors and their psychosocial repercussions (school level, repetition, intensity of symptoms, irritability, nervousness, substance use (cannabis, alcohol, tobacco), social relationships, family relationships, well-being, level of health literacy, learning disorders)) and to compare them with young people from the general school population.
For the epidemiological aspect:
To study the construct validity of the EnCLASS questions aiming to characterize handicap situations in the general school population in both a population in situation of psychic handicap and of somatic handicap.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021
NCT05795894
The 10-years REPEATERS Cohort of French Adolescents
NCT02887170
The Life Paths That Lead Teenagers to Attempted Suicide:Trajectories of Proximal Adversity
NCT04638205
Quantitative Study of Prevalence and Vulnerability Factors of Active Cyber Sexuality Among Teenagers in West Normandy
NCT03662321
Contribution of Psychological Autopsy to the Understanding of Suicidal Behaviors in French Overseas Territories
NCT05773898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, it appears from this review that the characteristics of the young people received have never been compared with those of students in a traditional education course. Characterizing this population meets a need, as well as a strong institutional demand (FSEF, funders and national education).
The EnCLASS-FSEF survey will be rolled out with the national EnCLASS methodology in all the annexes of the National Education schools integrated into the 13 FSEF care-study clinics (therefore on the total population in care-studies of the FSEF educated in secondary school) - making it possible to describe and compare the patients treated in care studies with the general school population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* From 11 years old,
* Non-opposition of the student to his participation in the study and to the use of his data (and of their parents for minor students).
Exclusion Criteria
11 Years
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Santé des Étudiants de France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathalie Godart
Role: STUDY_DIRECTOR
Fondation Santé des Etudiants de France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Godart Nathalie
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A02640-41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.